SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as investors weigh heavy options flow and the potential impact of its custom silicon deals ahead of its upcoming earnings report.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is trending as traders debate pre-order milestones and upcoming marketing catalysts for the highly anticipated Grand Theft Auto VI release.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is sliding near its 52-week lows as community members debate whether slowing traffic, consumer spending pressure, and value menu fatigue outweigh its status as a cash-flowing defensive real estate giant.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry shares are experiencing significant downward pressure despite management's recent upbeat commentary on QNX and robotics growth. The community is sharply divided, with frustrated long-term holders lamenting broken promises and missing catalysts while bears point to persistent valuation concerns and lack of near-term revenue acceleration.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics shares are trending upward amid strong community anticipation for upcoming clinical readouts and a potential short squeeze, while investors also digest recent regulatory setbacks for a competitor in the Duchenne muscular dystrophy space.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike shares surged following a strong quarterly report featuring a record net-new ARR increase and raised full-year guidance, which fueled widespread analyst price-target hikes. The community is actively debating the stock's lofty valuation alongside the broader thesis that escalating AI security threats are driving accelerated enterprise demand.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is trending amidst strong institutional inflows and upcoming governance network upgrades, with community members actively discussing price targets, staking benefits, and potential breakouts past key resistance levels.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

Community discussions are heavily focused on SentinelOne's valuation disconnect compared to cybersecurity peers, its strong growth metrics, and speculation regarding potential M&A interest from tech giants.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

Community discussions are heavily focused on upcoming votes for the Serra Verde acquisition and broader industry tailwinds from White House mining roundtables, while weighing the recent earnings report against long-term domestic supply chain growth.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is seeing heavy discussion as traders debate the impact of the company's slashed revenue guidance and falling antimony spot prices against its long-term domestic supply advantage.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Bessemer is swimming against the PE tide in Indian healthcare

… hospital chains and the broader healthcare provider sector. Central to Bessemer … cumulative PE investment in offline healthcare providers at $10.6 billion … such as Apollo Hospitals, Max Healthcare , Fortis Healthcare , Narayana Hrudayalaya, and others …

Narayana Hrudayalaya Forms Wholly Owned Subsidiary to Drive Northern India Expansion

Narayana Hrudayalaya Ltd. ( ($IN:NH) ) just unveiled an update. Narayana Hrudayalaya Ltd. has incorporated a new wholly owned subsidiary, Narayana ...

Brief Healthcare: ORMP: Advancing Clinical Activities and more

In this briefing: ORMP: Advancing Clinical Activities RVPH: Brilaroxazine Poster Presentations WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 Narayana Hrudayalaya: A Quarter of Record Performance and Strategic Expansion UltraGreen.ai IPO: High Growth and High Margins, Market Leader 1. ORMP: Advancing Clinical Activities ORMP is leveraging its strong balance sheet to invest in early stage companies, primarily focusing on the medical & biopharma space. ORMP has substantial liquidity as it both advances its oral drug delivery platform and pursues strategic opportunities, including strategic investments. The company received ~$27m on its Scilex investment in 3Q25, with the principal on the Scilex investment now fully repaid. 2. RVPH: Brilaroxazine Poster Presentations Reviva is a research and development pharmaceutical company with two portfolio compounds targeting nine indications. The candidates address multiple related mental disorders, rare diseases & other categories of un met need.

Brief Healthcare: RVPH: Brilaroxazine Poster Presentations and more

In this briefing: RVPH: Brilaroxazine Poster Presentations WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 Narayana Hrudayalaya: A Quarter of Record Performance and Strategic Expansion UltraGreen.ai IPO: High Growth and High Margins, Market Leader Monash IVF (MVF AU) Rejects Soul Patts/Genesis' Offer 1. RVPH: Brilaroxazine Poster Presentations Reviva is a research and development pharmaceutical company with two portfolio compounds targeting nine indications. The candidates address multiple related mental disorders, rare diseases & other categories of un met need. Reviva's lead indication in schizophrenia with brilaroxazine completed its Phase III RECOVER trial & may pursue future studies. 2. WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 Key takeaways from 3Q25 earnings release. Lu highlighted Ainos’ strong revenue momentum, up more than 4x Y/Y, driven almost entirely by the deployment of AI Nose in senior care programs.

Brief Healthcare: WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 and more

In this briefing: WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 Narayana Hrudayalaya: A Quarter of Record Performance and Strategic Expansion UltraGreen.ai IPO: High Growth and High Margins, Market Leader Monash IVF (MVF AU) Rejects Soul Patts/Genesis' Offer Madrigal Pharma: Inside the MAESTRO-NASH Breakthrough- How Weight Loss Supercharges Antifibrotic Effects! 1. WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 Key takeaways from 3Q25 earnings release. Lu highlighted Ainos’ strong revenue momentum, up more than 4x Y/Y, driven almost entirely by the deployment of AI Nose in senior care programs. Lu noted that the reported revenue has yet to include any of the $2.1-million, three-year AI Nose subscription order from a semiconductor customer, signaling additional upside in the SmellTech platform’s revenue, the turnaround in gross margin to 82% YTD from negative last year, and Ainos’ cost management with cash operating expenses reduced by 15% YTD versus the previous year.

Narayana Hrudayalaya shares climb 10% as Q2 net profit rises 30% to Rs 258.3 crore

Narayana Hrudayalaya shares saw a significant jump following strong quarterly results. The healthcare chain reported robust growth in revenue and profit for the September quarter. Both Indian and Cayman Islands operations contributed to this impressive performance. The company's net profit and operating revenue increased substantially year-on-year. This positive financial update has boosted investor confidence.

Narayana Hrudayalaya share price jumps over 7% on strong Q2 results; India, Cayman revenues highest ever

Narayana Hrudayalaya's share price rose over 7% after reporting record revenue and profitability for Q2FY26, with a net profit surge of 29.6% to ₹258 crore. Consolidated operating revenue increased by 20.3% to ₹1643.8 crore, driven by strong performance in both India and Cayman businesses.

Hospitals Get Pricing Relief: Fortis, Apollo, Max Healthcare Gain After Government Revises Rates For Nearly 2,000 Procedures

Equity

The CGHS revamp addresses long-standing concerns from private hospitals that earlier packages were outdated and failed to reflect rising medical costs

Narayana Hrudayalaya Faces Five Technical Red Flags: SEBI RA Warns Of An Overstretched Rally 

The stock has surged nearly 65% in 2025, but the analyst highlights a buildup of risk factors that could trigger a near-term correction.

Healthcare firm Narayana Hrudayalaya acquires prime land parcels in Bengaluru for ₹246 crore

Healthcare company Narayana Hrudayalaya Limited has … to documents accessed by Propstack. Healthcare company Narayana Hrudayalaya Limited has … along Bannerghatta Road, a prominent healthcare and residential corridor in south …

Narayana Hrudayalaya Ltd. engages in the provision of medical and health care services. It also provides services in the areas of cardiac surgery, cardiology, diabetes and endocrinology, gastroenterology, general surgery, neurosciences, facial surgery, nephrology, obstetrics and gynecology, orthopedics, oncology, pediatrics, transplant, urology, and vascular surgery; and other specialty services, such as dental, dermatology, emergency medicine, ears, nose, and throat, family medicine, general medicine, and genetic. The company was founded by Devi Prasad Shetty on July 19, 2000 and is headquartered in Bangalore, India.

Current Price	1,910.30
Prev Close	1,888.60
Open	1,891.30
Dividend Yield	0.28%
50-Day Moving Average	1,939.36
Beta	0.11
Avg. Volume	226,225.35
PE Ratio	47.38

52-Week High	2,093.30
52-Week Low	1,589.00
Market Capitalization	385.04B
EPS (Annual)	39.67
Price to Book	8.52
Revenue Per Employee	5.11M

Feed

News

Sentiment

Fundamentals

Info